Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
India is set to host diplomats of the 15-nation UN Security Council including the US, China and Russia, in October for a special meeting on counter-terrorism.
EXAMIANS